Skip to main content

and
  1. No Access

    Article

    Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer

    The new combination of ifosfamide and vinorelbine wasevaluated in a phase II study of patientswith metastatic breast cancer. All the patients hadevaluable or measurable lesions resistant to the combinationof c...

    P. Pronzato, P. Queirolo, M. Landucci, F. Vaira in Breast Cancer Research and Treatment (1997)

  2. No Access

    Article

    A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer

    We have evaluated the feasibility of an increase in dose intensity of the cisplatin, epidoxorubicin and cyclophosphamide (PEC) regimen, with granulocyte colony-stimulating factor (G-CSF) support, in 22 patient...

    P Pronzato, G Bertelli, A Vigani, F Vaira in British Journal of Cancer (1996)